X-Gen Pharmaceuticals Inc.: Drug Recall
Recall #D-0328-2021 · 03/19/2021
Class II: Risk
Recall Details
- Recall Number
- D-0328-2021
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- X-Gen Pharmaceuticals Inc.
- Status
- Terminated
- Date Initiated
- 03/19/2021
- Location
- Horseheads, NY, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 720 100-count (10x10 blister strips)
Reason for Recall
Failed Stability Specifications: Out of Specification (OOS) result reported for microbiological assay
Product Description
Neomycin Sulfate Tablets, USP 500mg, Rx Only, 10x10 Unit dose 100 Tablets, Manufactured for: X-GEN Phamaceuticals, Inc. Big Flats, NY 14814. NDC 39822-0310-5
Distribution Pattern
Distributed Nationwide in the USA
Other Recalls by X-Gen Pharmaceuticals Inc.
- Class III: Low Risk 04/02/2024
- Class III: Low Risk 04/02/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.